Litwin, Mark S.
Burnett School of Medicine,
United States
2025 Rank: 15528
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 154 out of 92052 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 15528 | 15199 |
| Total Cites | 23122 | 26256 |
| H-index | 72 | 78 |
| Hm-index | 30 | 32 |
| Number of Single Authored Papers | 33 | 33 |
| Total Cites to Single Authored Papers | 219 | 258 |
| Number of Single+First Authored Papers | 71 | 71 |
| Total Cites to Single+First Authored Papers | 5044 | 5530 |
| Number of Single+First+Last Authored Papers | 261 | 261 |
| Total Cites to Single+First+Last Authored Papers | 11542 | 12902 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 17156 | 18242 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.44 |
| Self-Citation Percentage |
11.94%
|
|
Litwin, Mark S.
David Geffen School of Medicine at UCLA,
United States
2024 Rank: 13606
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 136 out of 87532 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 13606 | 13318 |
| Total Cites | 22792 | 26096 |
| H-index | 72 | 78 |
| Hm-index | 30 | 31 |
| Number of Single Authored Papers | 33 | 33 |
| Total Cites to Single Authored Papers | 214 | 253 |
| Number of Single+First Authored Papers | 72 | 72 |
| Total Cites to Single+First Authored Papers | 5462 | 6115 |
| Number of Single+First+Last Authored Papers | 258 | 258 |
| Total Cites to Single+First+Last Authored Papers | 11707 | 13219 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 16224 | 17275 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.51 |
| Self-Citation Percentage |
12.66%
|
|
Litwin, Mark S.
David Geffen School of Medicine at UCLA,
United States
2023 Rank: 14188
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 147 out of 82885 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 14188 | 13760 |
| Total Cites | 20380 | 23291 |
| H-index | 70 | 76 |
| Hm-index | 30 | 31 |
| Number of Single Authored Papers | 33 | 33 |
| Total Cites to Single Authored Papers | 211 | 250 |
| Number of Single+First Authored Papers | 71 | 71 |
| Total Cites to Single+First Authored Papers | 4560 | 5041 |
| Number of Single+First+Last Authored Papers | 253 | 253 |
| Total Cites to Single+First+Last Authored Papers | 10559 | 11886 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 14911 | 15888 |
| Ratio of Total Citations to Distinct Citing Papers | 1.37 | 1.47 |
| Self-Citation Percentage |
12.50%
|
|
Litwin, Mark S.
University of California, Los Angeles,
United States
2022 Rank: 12280
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 120 out of 79729 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 12280 | 11858 |
| Total Cites | 20136 | 23287 |
| H-index | 70 | 76 |
| Hm-index | 29 | 30 |
| Number of Single Authored Papers | 32 | 32 |
| Total Cites to Single Authored Papers | 208 | 246 |
| Number of Single+First Authored Papers | 71 | 71 |
| Total Cites to Single+First Authored Papers | 4838 | 5473 |
| Number of Single+First+Last Authored Papers | 245 | 245 |
| Total Cites to Single+First+Last Authored Papers | 10506 | 11963 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 14028 | 15017 |
| Ratio of Total Citations to Distinct Citing Papers | 1.44 | 1.55 |
| Self-Citation Percentage |
13.53%
|
|
Litwin, Mark S.
University of California, Los Angeles,
United States
2021 Rank: 12202
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 116 out of 76322 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 12202 | 11861 |
| Total Cites | 19469 | 22494 |
| H-index | 68 | 74 |
| Hm-index | 28 | 29 |
| Number of Single Authored Papers | 32 | 32 |
| Total Cites to Single Authored Papers | 203 | 240 |
| Number of Single+First Authored Papers | 71 | 71 |
| Total Cites to Single+First Authored Papers | 4617 | 5218 |
| Number of Single+First+Last Authored Papers | 245 | 245 |
| Total Cites to Single+First+Last Authored Papers | 10132 | 11540 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 13552 | 14496 |
| Ratio of Total Citations to Distinct Citing Papers | 1.44 | 1.55 |
| Self-Citation Percentage |
13.45%
|
|
Litwin, Mark S.
David Geffen School of Medicine at UCLA,
United States
2020 Rank: 11738
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 119 out of 64516 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 11738 | 11173 |
| Total Cites | 17922 | 20838 |
| H-index | 66 | 72 |
| Hm-index | 27 | 29 |
| Number of Single Authored Papers | 32 | 32 |
| Total Cites to Single Authored Papers | 195 | 232 |
| Number of Single+First Authored Papers | 71 | 71 |
| Total Cites to Single+First Authored Papers | 4285 | 4878 |
| Number of Single+First+Last Authored Papers | 243 | 243 |
| Total Cites to Single+First+Last Authored Papers | 9414 | 10775 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 12296 | 13188 |
| Ratio of Total Citations to Distinct Citing Papers | 1.46 | 1.58 |
| Self-Citation Percentage |
13.99%
|
|